San Francisco, CA · Founded 2023 · Privately Held (backing)
Operator of a biopharmaceutical company intended to enhance the safety and efficacy of treatments for neurological diseases. Montara Therapeutics is based in San Francisco, CA and was founded in 2023. It was valued at $55 million at its seed round in Feb 2025, the last priced event on record. It has raised $28 million across 2 recorded rounds; the latest was a $20 million early-stage round in Feb 2025.
PMV mark · valuation
$55.0M
Oct 2026
Priced at
its seed round
Feb 2025
Total raised
$28.0M
Last round
Early Stage VC
Feb 2025
Cap table — not yet on record
Montara Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Montara Therapeutics with a free account
·Watch Montara Therapeutics: the Monday email on marks, rounds and moves
Where does Montara Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Montara Therapeutics's 2 recorded funding rounds.
